Navigation Links
First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs
Date:10/19/2007

HWI Scientist Dr. Dan Gewirth's Groundbreaking Research Makes Cover of

Molecular Cell

BUFFALO, N.Y., Oct. 19 /PRNewswire/ -- Dr. Dan Gewirth, Hauptman-Woodward senior research scientist, has just solved the structure of the first mammalian GRP94 protein implicated in immune diseases such as sepsis, AIDS and certain cancers. His work is being published today in a cover article in a top scientific journal -- Molecular Cell.

Gewirth's study confirms his 2001 hypothesis that this protein -- GRP94 -- is from the same family as the better known HSP90 proteins. As ligand-regulated chaperones -- proteins that help other cellular proteins achieve their active shapes, the HSP90s are key players in cellular regulation and recognition. The HSP90 proteins have been the subject of increasing international interest as scientists have discovered that they can be targeted therapeutically with drugs that lead to either stimulation as well as inhibition. For example, inhibitors of HSP90s are being developed as therapies for diseases ranging from cancer to sepsis, and drugs that stimulate HSP90 action may be appropriate therapies for diseases involving protein folding, such as cystic fibrosis, prion diseases, and Alzheimer's Disease.

Since 2001, Gewirth and his lab have been using the technique of X-ray diffraction to solve the first high-resolution structure of this protein from mammalian origins, to understand its function and to determine if it is indeed a member of the HSP90 family of proteins. The structure and activity patterns of this protein prove conclusively that this is indeed a member of the same family.

"Our work opens the door to a more intensive evaluation of this protein both from a mechanistic as well as a therapeutic point of view. In addition to aiding our understanding of the fundamental biology of chaperone-mediated protein folding, this work lays the foundation for the design of drugs that specificall
'/>"/>

SOURCE Hauptman-Woodward Medical Research Institute
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Aug. 27, 2015  Eli Lilly and Company (NYSE: ... Healthcare Conference on Thursday, September 17, 2015. Sue ... Lilly Oncology and Richard Gaynor , M.D., senior ... Lilly Oncology, will participate in a fireside chat at ... live audio webcast will be available on the "Webcasts ...
(Date:8/27/2015)... 27, 2015   Women Grow , the fastest-growing professional networking ... with the Cannabis World Congress & Business Exposition ... 15 business-focused educational sessions. CWCBExpo in LA will take place ... Convention Center in Los Angeles, CA ... Coast for the marijuana industry. The Women Grow ...
(Date:8/27/2015)...  MiMedx Group, Inc. (NASDAQ: MDXG ), ... tissue and patent-protected processes to develop and market ... Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental ... multiple inaccuracies in the press release issued by ... rulings from the Patent Trial and Appeal Board ...
Breaking Medicine Technology:Lilly to Participate in Morgan Stanley Global Healthcare Conference 2Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 2Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 3Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 4MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 2MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 3MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 4
... The Consumer Healthcare Products Association (CHPA), representing ... children, applauds the U.S. Food and Drug Administration ... their children the right amount of medicine. Today, ... Advisory Committee recommended enhancing the labels of all ...
... (NYSE: LLY ) today announced that David M. ... American Diabetes Association, has been named distinguished medical fellow for ... In his new role, Kendall will serve as ... clinical science communities and as a representative to the professional ...
Cached Medicine Technology:OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions 2OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions 3David M. Kendall, M.D., Named Distinguished Medical Fellow at Lilly 2David M. Kendall, M.D., Named Distinguished Medical Fellow at Lilly 3
(Date:8/27/2015)... ... , ... In an article published July 30th by the New ... Orleans, highlighting a security firm that is tasked with providing supplemental protection. Called the ... worked with the city to provide private security when it is needed in a ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... one of just 20 adult-only medical centers in the United States to receive ... hearts and lungs. The Extracorporeal Life Support Organization (ELSO) , an international ...
(Date:8/27/2015)... ... 27, 2015 , ... On May 30th, 2015, at the Adams County Fairgrounds ... the “Music With A Mission” benefit concert. For the past two years, “Music With ... underfunded school districts of Mendon and neighboring town, Quincy, IL. Organized in part by ...
(Date:8/27/2015)... WILMINGTON, Del. (PRWEB) , ... August 27, 2015 , ... ... Hospital, will be the guest speaker at CURE® magazine’s 3rd Annual MPN Heroes™ ... , Dr. Arnold will be among hundreds of attendees honoring eight heroes who have ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... , scheduled for October 27-29, 2015 in San Jose, CA. The first ... primarily focus on the void that exists where battery development and energy storage ...
Breaking Medicine News(10 mins):Health News:Article on New Orleans Security Force Highlights the Abilities and Flexibility of Private Security, says Spear Security Inc. 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 4Health News:Best Drug Rehabilitation Interviews Madd Hoss Jackson at the 2015 "Music With A Mission" Benefit Concert 2Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 2Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 3Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 4Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2
... NY, October 6, 2010 In recognition of the 20th ... (ADA), the October issue of Disability and Health Journal ... whether the ADA has in fact improved the health of ... acknowledging physical barriers and need for better staff training and ...
... about unethical U.S. studies on syphilis in Guatemala in the ... has written a commentary for Bioethics Forum , the ... learn from history to better protect human subjects in the ... Wellesley College, describes how she unearthed documents about the study ...
... at the Johns Hopkins Bloomberg School of Public Health ... Reviewed Orthopaedic Research Program (PRORP) of the U.S. Department ... Research Consortium (METRC). The Consortium, which was established in ... DOD, conducts multi-center studies relevant to the treatment and ...
... Reinberg HealthDay Reporter , THURSDAY, Oct. 7 (HealthDay ... illness and help prevent the spread of flu, many Americans ... this coming season, new surveys reveal. Despite the attention ... Americans say they will not be getting the vaccine this ...
... ANN ARBOR, Mich.Clinical trials in which participants are randomly ... of clinical research. When conducted correctly, it,s widely accepted ... and can be trusted. But researchers ... process for bringing therapies and medical devices to patients ...
... AURORA, Colorado (Oct. 6, 2010) The University of Colorado ... University of Colorado School of Medicine, has been awarded $6.3 ... emphasis on donors from minority groups. The three-year ... division of the United States Department of Health and Human ...
Cached Medicine News:Health News:Disability and Health Journal critically examines Americans with Disabilities Act 2Health News:Disability and Health Journal critically examines Americans with Disabilities Act 3Health News:Disability and Health Journal critically examines Americans with Disabilities Act 4Health News:Additional $38M awarded to expand orthopedic trauma care research 2Health News:Many Americans Plan to Skip Flu Shot This Year 2Health News:Many Americans Plan to Skip Flu Shot This Year 3Health News:U-M receives NIH, FDA grant to study adaptive clinical trial designs 2Health News:University of Colorado gets federal award for Cord Blood Bank 2
... and negative whole blood control to test ... solubility tests and hemoglobin electrophoresis. Sickle-Chex is ... manufacturers' solubility kits. Sickle-Chex is packaged in ... vial dispenses an accurate sample volume. No ...
... three-part differential control assayed for all parameters on ... Series, AcT/AcT diff/AcT diff2, MD Series and ONYX ... 1800; ABX Micros 60; and Diatron Abacus and ... stability of 30 days and a six-month closed-vial ...
... Cell-Chex Auto is a whole blood ... of hematology instruments that measure automated blood ... The assay provides total RBC and WBC ... and Sapphire, Beckman Coulter LH750/LH 755 (levels ...
iSleep 20i is an advanced high performance CPAP with outstanding self-adjusting i‑technology....
Medicine Products: